pharmacology - Viral Buzz News

<!-- Histats.com  START  (aync)-->
<script type="text/javascript">var _Hasync= _Hasync|| [];
_Hasync.push(['Histats.start', '1,4915487,4,0,0,0,00010000']);
_Hasync.push(['Histats.fasi', '1']);
_Hasync.push(['Histats.track_hits', '']);
(function() {
var hs = document.createElement('script'); hs.type = 'text/javascript'; hs.async = true;
hs.src = ('//s10.histats.com/js15_as.js');
(document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(hs);
})();</script>
<noscript><a href="/" target="_blank"><img  src="//sstatic1.histats.com/0.gif?4915487&101" alt="" border="0"></a></noscript>
<!-- Histats.com  END  -->

Palvella Therapeutics Gains New U.S. Patent for Innovative QTORIN Rapamycin Technology

admin3 months ago03 mins

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has been awarded its fifth U.S. patent for QTORIN™ 3.9% rapamycin anhydrous gel, strengthening its role in developing therapies for uncommon dermatological conditions. This recently issued patent number 12,268,673 prolongs the patent coverage for QTORIN™ rapamycin until 2038 and includes claims related to its formulation as well…